Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Farrell and David Andrews.
Connection Strength
1.579
-
Andrews DW, Farrell CJ. We can control the tumor but can we stop the pain? World Neurosurg. 2013 Sep-Oct; 80(3-4):290-2.
Score: 0.507
-
Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW. Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. J Neurooncol. 2018 Mar; 137(1):179.
Score: 0.189
-
Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. J Neurooncol. 2018 Mar; 137(1):171-177.
Score: 0.186
-
Champ CE, Shen X, Shi W, Mayekar SU, Chapman K, Werner-Wasik M, Farrell CJ, Gunn V, Downes MB, Liu H, Evans JJ, Andrews DW. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation. Neurosurgery. 2013 Sep; 73(3):489-96.
Score: 0.138
-
Khanna O, Fathi Kazerooni A, Farrell CJ, Baldassari MP, Alexander TD, Karsy M, Greenberger BA, Garcia JA, Sako C, Evans JJ, Judy KD, Andrews DW, Flanders AE, Sharan AD, Dicker AP, Shi W, Davatzikos C. Machine Learning Using Multiparametric Magnetic Resonance Imaging Radiomic Feature Analysis to Predict Ki-67 in World Health Organization Grade I Meningiomas. Neurosurgery. 2021 Oct 13; 89(5):928-936.
Score: 0.061
-
Nowak-Choi K, Palmer JD, Casey J, Chitale A, Kalchman I, Buss E, Keith SW, Hegarty SE, Curtis M, Solomides C, Shi W, Judy K, Andrews DW, Farrell C, Werner-Wasik M. Resected WHO grade I meningioma and predictors of local control. J Neurooncol. 2021 Jan 09.
Score: 0.058
-
Song A, Bar-Ad V, Martinez N, Glass J, Andrews DW, Judy K, Evans JJ, Farrell CJ, Werner-Wasik M, Chervoneva I, Ly M, Palmer JD, Liu H, Shi W. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma. J Neurooncol. 2020 Mar 23.
Score: 0.055
-
Palmer JD, Bhamidipati D, Shukla G, Sharma D, Glass J, Kim L, Evans JJ, Judy K, Farrell C, Andrews DW, Wang ZW, Peiper SC, Werner-Wasik M, Shi W. Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients. Am J Clin Oncol. 2019 May; 42(5):481-486.
Score: 0.051
-
Song A, Andrews DW, Werner-Wasik M, Kim L, Glass J, Bar-Ad V, Evans JJ, Farrell CJ, Judy KD, Daskalakis C, Zhan T, Shi W. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas. Radiother Oncol. 2019 Mar; 132:135-141.
Score: 0.050
-
Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases. Int J Radiat Oncol Biol Phys. 2017 Sep 01; 99(1):22-30.
Score: 0.045
-
Belinsky I, Murchison AP, Evans JJ, Andrews DW, Farrell CJ, Casey JP, Curtis MT, Nowak Choi KA, Werner-Wasik M, Bilyk JR. Spheno-Orbital Meningiomas: An Analysis Based on World Health Organization Classification and Ki-67 Proliferative Index. Ophthal Plast Reconstr Surg. 2017 Mar 27.
Score: 0.044
-
Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. J Neurooncol. 2016 May; 127(3):535-9.
Score: 0.041
-
Shi W, Jain V, Kim H, Champ C, Jain G, Farrell C, Andrews DW, Judy K, Liu H, Artz G, Werner-Wasik M, Evans JJ. Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas. J Neurol Surg B Skull Base. 2016 Feb; 77(1):75-80.
Score: 0.040
-
Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. J Neurooncol. 2015 Sep; 124(2):215-21.
Score: 0.039
-
Kim H, Potrebko P, Rivera A, Liu H, Eldredge-Hindy HB, Gunn V, Werner-Wasik M, Andrews DW, Evans JJ, Farrell CJ, Judy K, Shi W. Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma. Radiother Oncol. 2015 May; 115(2):229-34.
Score: 0.039
-
Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP. Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial. J Neurooncol. 2014 Jun; 118(2):313-9.
Score: 0.036